U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Gentamicin Sulfate Injection
Status: Currently in Shortage
»Date first posted: 07/23/2021
»Therapeutic Categories: Anti-Infective

Expand all

Baxter (Revised 08/31/2022)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 60 mg/50 mL, (NDC 0338-0507-41) Available
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 80 mg/50 mL, (NDC 0338-0509-41) Available
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 80mg/100 mL, (NDC 0338-0503-48) Available
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 100 mg/50 mL, (NDC 0338-0511-41) Available
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 100 mg/100 mL, (NDC 0338-0505-48) Available
Gentamicin Sulfate in 0.9% Sodium Chloride Injection, 120 mg/100 mL, (NDC 0338-0507-48) Available

Fresenius Kabi USA, LLC (Reverified 03/10/2023)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
80 mg per 2 mL (40 mg per mL), MDV, (NDC 63323-010-02) Available Check wholesaler inventory Demand increase for the drug
800 mg per 20 mL (40 mg per mL), MDV, (NDC 63323-010-20) Available Check wholesaler inventory Demand increase for the drug
20 mg per 2 mL (10 mg per mL), Pediatric SDV, (NDC 63323-173-02) Available Check wholesaler inventory Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (New 03/23/2023)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg/mL, 2 mL vial (NDC 0143-9128-25) This presentation is temporarily on backorder. Additional lots will be available in the May 2023 timeframe. Product will be made available as it is released. Demand increase for the drug

Hospira, Inc., a Pfizer company (Reverified 03/17/2023)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
80 mg/2 mL (40 mg/mL); 2 mL Single Dose Glass Fliptop Vial (NDC 00409-1207-03) Next Delivery and Estimated Recovery: December 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
80 mg/2 mL (40 mg/mL) Single Dose Glass Fliptop Vial NovaPlus (NDC 00409-1207-25) Next Delivery and Estimated Recovery: December 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
Back to Top